The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 46,146 | 3,495,943 | SH | SOLE | 3,495,943 | 0 | 0 | ||
5 01 ACQUISITION CORP | COM CL A | 33836P105 | 1,980 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 84,420 | 5,991,479 | SH | SOLE | 5,991,479 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 1,256 | 1,046,700 | SH | SOLE | 1,046,700 | 0 | 0 | ||
AKOUOS INC | COM | 00973J101 | 9,267 | 1,975,984 | SH | SOLE | 1,975,984 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 41,215 | 4,056,548 | SH | SOLE | 4,056,548 | 0 | 0 | ||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 4,778 | 3,948,360 | SH | SOLE | 3,948,360 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 51,165 | 4,488,200 | SH | SOLE | 4,488,200 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 152,677 | 7,521,024 | SH | SOLE | 7,521,024 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 234,395 | 5,183,431 | SH | SOLE | 5,183,431 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 19,083 | 895,503 | SH | SOLE | 895,503 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 47,360 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 131,460 | 3,123,300 | SH | SOLE | 3,123,300 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,472 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 45,019 | 6,340,639 | SH | SOLE | 6,340,639 | 0 | 0 | ||
AVEO PHARMACEUTICALS INC | COM NEW | 053588307 | 4,248 | 647,489 | SH | SOLE | 647,489 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 40,096 | 2,759,505 | SH | SOLE | 2,759,505 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 1,980 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 306 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 363 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 3,106 | 115,200 | SH | Put | SOLE | 115,200 | 0 | 0 | |
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 1,424 | 292,320 | SH | SOLE | 292,320 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 43,527 | 1,646,260 | SH | SOLE | 1,646,260 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 12,068 | 690,000 | SH | SOLE | 690,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 24,809 | 1,330,263 | SH | SOLE | 1,330,263 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 14,998 | 1,169,889 | SH | SOLE | 1,169,889 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 36,878 | 2,634,178 | SH | SOLE | 2,634,178 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 1,477 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 18,784 | 2,359,808 | SH | SOLE | 2,359,808 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 3,779 | 678,441 | SH | SOLE | 678,441 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 1,980 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 660 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
EVELO BIOSCIENCES INC | COM | 299734103 | 423 | 200,417 | SH | SOLE | 200,417 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 15,823 | 760,000 | SH | Call | SOLE | 760,000 | 0 | 0 | |
FRAZIER LIFESCIENCES ACQU CO | *W EXP 11/30/202 | G3710A113 | 658 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | CL A SHS | G3710A105 | 5,800 | 587,615 | SH | SOLE | 587,615 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 178,420 | 3,197,500 | SH | SOLE | 3,197,500 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 21,962 | 14,168,988 | SH | SOLE | 14,168,988 | 0 | 0 | ||
GRACELL BIOTECHNOLOGIES INC | SPONSORED ADS | 38406L103 | 10,567 | 1,921,310 | SH | SOLE | 1,921,310 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 3,196 | 1,162,179 | SH | SOLE | 1,162,179 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,984 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HOOKIPA PHARMA INC | COM | 43906K100 | 8,150 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 13,886 | 182,783 | SH | SOLE | 182,783 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 5,768 | 279,999 | SH | SOLE | 279,999 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 17,354 | 1,421,319 | SH | SOLE | 1,421,319 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 4,940 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 2,207 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 1,189 | 326,780 | SH | SOLE | 326,780 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 121,681 | 6,638,371 | SH | SOLE | 6,638,371 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 1,437 | 310,960 | SH | SOLE | 310,960 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 85,749 | 3,951,566 | SH | SOLE | 3,951,566 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 6,937 | 541,108 | SH | SOLE | 541,108 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 3,121 | 963,333 | SH | SOLE | 963,333 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 45,025 | 13,896,543 | SH | SOLE | 13,896,543 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 1,440 | 353,701 | SH | SOLE | 353,701 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 493 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 15,313 | 3,418,068 | SH | SOLE | 3,418,068 | 0 | 0 | ||
OVID THERAPEUTICS INC | COM | 690469101 | 13,152 | 6,117,400 | SH | SOLE | 6,117,400 | 0 | 0 | ||
PARDES BIOSCIENCES INC | COM | 69945Q105 | 614 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 515 | 210,100 | SH | SOLE | 210,100 | 0 | 0 | ||
PRECISION BIOSCIENCES INC | COM | 74019P108 | 8,058 | 5,035,971 | SH | SOLE | 5,035,971 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 314,513 | 11,584,280 | SH | SOLE | 11,584,280 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 60,039 | 1,975,611 | SH | SOLE | 1,975,611 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 62,369 | 3,723,541 | SH | SOLE | 3,723,541 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 83,380 | 4,278,069 | SH | SOLE | 4,278,069 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 214,996 | 2,868,145 | SH | SOLE | 2,868,145 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 178,467 | 1,008,628 | SH | SOLE | 1,008,628 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 4,585 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 2,440 | 575,359 | SH | SOLE | 575,359 | 0 | 0 | ||
SURFACE ONCOLOGY INC | COM | 86877M209 | 7,631 | 4,653,000 | SH | SOLE | 4,653,000 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 200 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 10,428 | 2,302,065 | SH | SOLE | 2,302,065 | 0 | 0 | ||
TEMPEST THERAPEUTICS INC | COM | 87978U108 | 2,217 | 1,031,268 | SH | SOLE | 1,031,268 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 993 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 331 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 15,899 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 1,507 | 98,593 | SH | SOLE | 98,593 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 28,096 | 4,753,907 | SH | SOLE | 4,753,907 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 144,580 | 5,282,416 | SH | SOLE | 5,282,416 | 0 | 0 | ||
ZAI LAB LT | ADR | 98887Q104 | 84,338 | 2,431,885 | SH | SOLE | 2,431,885 | 0 | 0 |